ADVANCED FORMULATION Dermelle scar therapy gel

Dermelle by

Drug Labeling and Warnings

Dermelle by is a Other medication manufactured, distributed, or labeled by Scite Pharma, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DERMELLE- dressing, wound, occlusive    
Scite Pharma, LLC

----------

ADVANCED
FORMULATION
Dermelle
scar therapy gel

Rx Only
For topical use only

Federal Law restricts this device to sale by or on the order of a licensed healthcare practitioner.

Description

Dermelle is a transparent gel formulation for the management of scars, both old and new.

When used as directed Dermelle dries to form a protective layer that is gas permeable and waterproof which hydrates and protects scars from chemical and microbial invasion, allowing scars to normalize the collagen synthesis cycles, producing a normal mature scar.

Dermelle is suitable for all areas of the skin, including exposed areas like the face and neck as well as joints and hairy areas without the need for shaving.

Indication for use

Dermelle is intended to be used under the direction of healthcare practitioners in the management of scars.

Dermelle is indicated for the use on all types of scars including those resulting from:

  • general and cosmetic surgery
  • trauma
  • chronic wounds
  • burns
  • bites
  • acne, and other diseases of the skin.

Dermelle is indicated to soften and flatten scars, relieve the itching and discomfort as well as to reduce redness and discoloration associated with scars.

Dermelle is used for the topical management of keloids and hypertrophic scars.

It contains no alcohols, parabens or fragrances.

Dermelle is suitable for children or people with sensitive skin.

Dermelle is suitable to use on infants, during pregnancy and whilst breastfeeding.

Dermelle is intended for single patient use.

image

On the first use of 1 oz (28.5 g) tubes remove the cap, then the protective seal and close with the cap after use.

Directions for use

Ensure that the scar is clean and dry.

Apply a very thin layer of Dermelle to the scar and allow to dry.

When applied correctly, Dermelle should be dry in 3–4 minutes.

If it takes longer to dry you have probably applied too much. Gently remove the excess with a tissue and allow the drying process to continue.

Once dry, Dermelle can be covered with sunscreen, cosmetics, pressure garments or casts.

Dermelle should be applied once daily, or twice daily to exposed areas or as advised by your physician.

For best results Dermelle should be maintained in continuous contact with the skin (24 hours a day/7 days a week).

How much Dermelle do I need?

Dermelle gel is an advanced formulation that requires substantially less product per application than typical creams or gels.

Dermelle 1 oz (28.5 g) is enough to treat an area of 5 × 5 inch (12 × 12 cm) twice per day for 30 days.

Warning

  • For external use only.
  • Dermelle should not be applied on third degree burns or to open wounds.
  • Dermelle should not be placed in contact with mucous membranes or the eyes.
  • Dermelle should not be applied over topical medications unless advised by your physician.
  • Dermelle may stain clothing if not completely dry. If staining occurs, dry cleaning should be able to remove it without damaging the fabric.
  • For correct storage please reclose the tube tightly with the cap.
  • If irritation occurs, discontinue use and consult your physician.
  • Keep out of the reach of children.
  • Do not use after the expiration (EXP) date printed on the tube. The expiration (EXP) date does not change once the tube has been opened.
  • Do not use if the tube is damaged.

Contraindications

Do not administer to patients with known hypersensitivity to the ingredients of this product.

Ingredients: Polydimethylsiloxane, hydroxylsiloxane and alkyl siloxane resin.

How supplied

Dermelle 1 oz (28.5 g) tube

Product identification code: 79043-110-28

image

Consult instructions for use

image

Use by date

image

Batch code

image

Upper limit of temperature

Stratpharma AG
Aeschenvorstadt 57
CH-4051 Basel
Switzerland

Distributed by
Allegis Pharmaceuticals
Canton, MS 39046, USA

Date of preparation of this
information: 09/2020

Stratpharma
Switzerland

scite
PHARMA

Questions:
1-866-633-9033

CE

DM000USENPI01-1020

PRINCIPAL DISPLAY PANEL - 28.5 g Tube Box

79043-110-28

Rx Only
For topical use only

gel
1 oz
28.5 g

ADVANCED
FORMULATION

Dermelle
scar therapy gel

PRINCIPAL DISPLAY PANEL - 28.5 g Tube Box
DERMELLE 
dressing, wound, occlusive
Product Information
Product TypeMEDICAL DEVICEItem Code (Source)NHRIC:79043-110
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
DIMETHICONOL (2000 CST) (UNII: T74O12AN6Y)  
CAPRYLYL TRISILOXANE (UNII: Q95M2P1KJL)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NHRIC:79043-110-281 in 1 BOX
128.5 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Exempt deviceMDA12/15/202012/01/2025
Labeler - Scite Pharma, LLC (117555106)

Revised: 7/2023
 

Trademark Results [Dermelle]

Mark Image

Registration | Serial
Company
Trademark
Application Date
DERMELLE
DERMELLE
90322379 not registered Live/Pending
Velocity Consulting Specialist, LLC
2020-11-16
DERMELLE
DERMELLE
73592253 1419681 Dead/Cancelled
RINGEL, CHARLES
1986-04-08

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.